Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...

Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...

In February 2016, a gangland murder in broad-daylight shocked the nation of Ireland, and it involved the uncle of a young man ...

The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...

The 2025 roster of 18 gymnasts features 12 returners and six true freshmen (Love Birt, Brooke Dennis, Ryan Fuller, Kylee ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Brown visits Yale in Ivy League play Saturday. Saturday's meeting is the first this season between the two squads.

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...